Resources
… Due to their mode of production, therapeutic glycoproteins present complex and heterogeneous glycosylations. … comprehensive workflow is fully applicable to other glycoproteins, such as mAbs, ADCs, and other proteins produced by the recombinant DNA technology, using …
CPhI WorldWide 2017
Events
… advances we’ll be presenting at CPhI Worldwide: ICH Q3D compliance: analytical testing and risk assessment …
2D-LC–MS for the Analysis of Monoclonal Antibodies and Antibody–Drug Conjugates in a Regulated Environment
Article
… [GLP], and good clinical laboratory practice [GCLP] compliance). High-resolution MS is indeed a powerful tool … [GLP], and good clinical laboratory practice [GCLP] compliance). High-resolution MS is indeed a powerful tool …
State-of-the-Art MS Methods for Structural Assessment of mAbs and ADCs: From the Research Lab to Routine Characterization
Article
… antibodies (mAbs) are highly complex tetrameric glycoproteins that require extensive analytical and structural … with MS detection is widely used for the identification of proteins from complex proteome samples in many laboratories. …
Potency assays
Services
Antibody Industrial Symposium 2025
Events
… are here to support your developments of mAbs , ADCs and proteins. 12 years’ experience with CBMPs: Cell-Based …
Resources
… can affect the stability and efficacy of biotherapeutic proteins. … … Characterizing Deamidation and Oxidation in …
Resources
… range of techniques, due to high heterogeneity of these proteins. This heterogeneity is due to post-translational …
TIDES Europe
Events
… peptides are at the crossroads of small molecules and proteins, requiring specific analytical packages depending …